Skip to search formSkip to main contentSkip to account menu

Inhibition of Matrix Metalloproteinases Pathway

Known as: Inhibition of Matrix Metalloproteinases 
Cellular transformation is accompanied by many cellular changes, including uncontrolled proliferation, loss of the differentiated cell morphology… 
National Institutes of Health

Related topics

Related topics

14 relations
HRAS wt AlleleMMP14 protein, humanMMP14 wt AlleleMMP2 wt Allele

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Alpha‐pinene attenuates UVA‐induced photoaging through inhibition of matrix metalloproteinases expression in mouse skin
Review
2016
Review
2016
Emerging Adjuvant Therapy for Cancer: Propolis and its Constituents
ABSTRACT Propolis is a bee-metabolized resinous substance (bee glue) from plant sap and gums. It has been in usage as a healing… 
2016
2016
Deficiency and Also Transgenic Overexpression of Timp-3 Both Lead to Compromised Bone Mass and Architecture In Vivo
Tissue inhibitor of metalloproteinases-3 (TIMP-3) regulates extracellular matrix via its inhibition of matrix metalloproteinases… 
2012
2012
Development and validation of novel enzyme activity methods to assess inhibition of matrix metalloproteinases (MMPs) in human serum by antibodies against enzyme therapeutics.
2009
2009
Differential inhibition of matrix metalloproteinases-2, -9, and -13 activities by selected anthraquinones.
Matrix metalloproteinases (MMPs) play an important role in physiological and pathological matrix remodeling. Here, we report that… 
2008
2008
A24 INHIBITION OF MATRIX METALLOPROTEINASES ENHANCES IN VITRO REPAIR OF THE MENISCUS
2007
2007
Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.
2006
2006
Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix…
Highly Cited
2005
Highly Cited
2005
Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
OBJECTIVE To study the effects of a matrix metalloproteinase (MMP) inhibitor (S-34219) on osteoarthritis (OA) cartilage cultures… 
Highly Cited
2005
Highly Cited
2005
Reactive Site Mutations in Tissue Inhibitor of Metalloproteinase-3 Disrupt Inhibition of Matrix Metalloproteinases but Not Tumor Necrosis Factor-α-converting Enzyme*
Tissue inhibitor of metalloproteinase-3 (TIMP-3) is a dual inhibitor of the matrix metalloproteinases (MMPs) and some adamalysins… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)